HOME >> MEDICINE >> NEWS
Promising drug fails to improve COPD symptoms

NF-, and a number of studies have reported increased production of TNF in COPD patients. This increased production has been linked to weight loss, muscle weakness and muscle loss.

In addition, animal studies supported the prospect using the drug in COPD. When TNF- was infused into rats, they developed emphysema, which, along with chronic bronchitis, makes up most COPD cases. When the TNF- receptor was turned off in mice, they were less likely than mice that had not be genetically altered to develop emphysema when exposed to chronic cigarette smoke.

The latest study, however, did confirm a recently reported pilot study that found no improvement among the 14 COPD patients given infliximab.

In attempting to explain the disappointing results, the study authors speculate that, despite infliximab's efficacy in treating other inflammatory diseases, it may not be effective in COPD because other mediators, in addition to TNF-, are necessary to cause COPD. They also concede that six months may simply be too short a time period to see improvement.

However, an increased number of malignancies observed in infliximab-treated subjects, the authors said, raised concern about the safety of this drug in lung patients. Although the malignancies may have been present when the patients enrolled in the study, "the possibility that infliximab contributed to the progession, and thus the diagnosis, of malignancies remains a serious concern."

This safety issue, coupled with the "resoundingly negative results," make in unlikely that a longer trial will be undertaken, according to the accompanying editorial.


'"/>

Contact: Suzy Martin
smartin@thoracic.org
212-315-8631
American Thoracic Society
1-May-2007


Page: 1 2

Related medicine news :

1. Promising therapy for ALS delivers antisense drug directly to nervous system
2. Promising new treatment for ulcerative colitis sufferers
3. Promising advance in breast cancer research
4. Promising obesity therapy receives follow-on funding
5. Promising diagnostic tools for multiple sclerosis developed at Yale
6. Promising therapies for haemophilia & heart disease
7. Promising new TB drug enters clinical trial
8. Promising new West Nile therapy cures disease in mice
9. Government fails sleepy Judge Dodd
10. Pairing medical therapy with coronary intervention fails to reduce heart disease deaths
11. Community and clinic-based HIV-1 control program fails to decrease incidence of HIV-1 in Zimbabwe

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/5/2016)... ... 2016 , ... Liposuction specialist Marcia V. Byrd, MD spoke last month at ... Marriot St. Louis Airport Hotel. This year’s conference was titled “Living with Lipedema and ... unique specialization in treating Lipedema. Dr. Byrd is considered one of the leading physicians ...
(Date:5/5/2016)... ... ... Linfield College Online and Continuing Education is encouraging registered nurses to apply ... for all qualified applicants from May 1–14. Students need only go to the application ... , With the RN to BSN degree program, all core classes ...
(Date:5/5/2016)... Springfield, OR (PRWEB) , ... May 05, 2016 , ... ... Assembly at Riverbend Elementary School last week to raise non-perishable food item donations for ... event “Red Nose Day” hosted on NBC. , “The goal of the assembly was ...
(Date:5/5/2016)... ... May 05, 2016 , ... In the midst of ... forget the most important arrangement — planning a safe way of getting home after ... tequila drinks. Unfortunately, these celebrations often lead to drunk drivers on the roads who ...
(Date:5/5/2016)... ... ... Augusta Public Schools has teamed with CareDox to provide confidential and safe ... to streamline and bolster care for district students. , Augusta School District, USD ... serve 2,300 students among its six schools. , Monica Guilliams, BSN, RN, is ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... 4, 2016  Compass Diversified Holdings (NYSE: ... owner of leading middle market businesses, announced today its ... 31, 2016. First Quarter 2016 Highlights ... ("CAD" or "Cash Flow") of $13.6 million for the ... of $15.0 million for the first quarter of 2016; ...
(Date:5/4/2016)... ALBANY, New York , May 4, 2016 /PRNewswire/ ... published by Transparency Market Research entitled "Brain Computer Interface Market ... Forecast 2016 - 2024," the  global brain computer interface (BCI) ... bn by 2024. The market is estimated to expand ... period from 2016 to 2024. A BCI ...
(Date:5/4/2016)... Calif. , May 4, 2016  It,s time for an upgrade. There are ... on a brilliant 3.5 inch LCD, the illustrious DVMAXX HD  offers unparalleled connectivity ... as well as a world class manufacturer of innovative technology.  Photo - ... ... ...
Breaking Medicine Technology:
Cached News: